Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net sales	$ 1,367,000	$ 383,000
Cost of goods sold	1,853,000	497,000
Gross loss	(486,000)	(114,000)
Operating expenses:
Research and development	12,824,000	4,357,000
Sales and marketing	7,196,000	1,745,000
General and administrative	41,792,000	2,493,000
Operating expenses	61,812,000	8,595,000
Loss from operations	(62,298,000)	(8,709,000)
Other income (expense):
Interest expense, net	(40,044,000)	(3,684,000)
Other expense, net	(2,337,000)	(2,317,000)
Loss before income taxes	(104,679,000)	(14,710,000)
Income tax provision	(3,000)	(4,000)
Net loss	$ (104,682,000)	$ (14,714,000)
Net loss attributable per share to common stockholders, basic and diluted	$ (1.19)	$ (0.23)
Weighted-average shares used to compute net loss attributable per share to common stockholders, basic and diluted	87,705,256	62,811,287